Literature DB >> 23285441

The profile of voluntary reported adverse drug reactions at a tertiary care hospital: a fifteen month prospective study.

Amit Dang1, P N Bhandare.   

Abstract

OBJECTIVES: The present study was undertaken to provide the health professionals who were working at a tertiary care hospital, with a simple method to report Adverse Drug Reactions (ADRs) and to monitor, document and to evaluate them according to the set criteria. METHOD AND MATERIALS: This study was conducted over a period of 15 months from 1st Jan' 2008 to 31st March 2009 at Goa Medical College and Hospital (Goa, India). The evaluation of the data was done for various parameters, which included patient demographics and drug and reaction characteristics. An assessment was also done for the outcome, causality and the severity of the drug reactions.
RESULTS: A total of 265 ADRs were reported. Among the drugs, the ß-lactam antibiotics were implicated the maximum number of times (54, 20.37%), followed by fluoroquinolones (35, 13.20%), antiretrovirals (33, 12.45%) and antiepileptics (31, 11.69%). Females showed more ADRs (142, 54%) than males (123, 46%). The skin was involved in about 57.73% (153) of the ADRs, while the CNS and the vascular system were involved in 8.67% (23) and 8.30% (22) of the ADRs. Most of the ADRs were categorized as "Type II" (203, 77%) against "Type I" (62, 23%) by Rawlins and Thompson's classification. The causality assessment was done by the Naranjo Algorithm and 62.26% (165) were seen to fall in the "probable category" as compared to 29.05% (77) in the "highly probable" one. Out of all the ADRs which were reported, 34.71% (148) were "severe", in accordance with the Modified Hartwig and Siegel's scale.
CONCLUSION: The present work was a humble attempt to set up a well organized ADR reporting system at our government hospital. The systematic tracking and monitoring of ADRs can shed light on their extensiveness and their patterns of occurrence.

Entities:  

Keywords:  ADR drop box; Adverse Drug Reactions; Pharmacovigilance

Year:  2012        PMID: 23285441      PMCID: PMC3527781          DOI: 10.7860/JCDR/2012/4340.2544

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  27 in total

1.  Postmarketing surveillance and adverse drug reactions: current perspectives and future needs.

Authors:  T Brewer; G A Colditz
Journal:  JAMA       Date:  1999-03-03       Impact factor: 56.272

2.  [Preventability of adverse effects in a medical emergency service].

Authors:  P Olivier; O Boulbès; M Tubery; P Carles; J L Montastruc; M Lapeyre-Mestre
Journal:  Therapie       Date:  2001 May-Jun       Impact factor: 2.070

3.  Adverse reactions induced by NSAIDs and antibacterials: analysis of spontaneous reports from the Sicilian regional database.

Authors:  Giovanni Polimeni; Francesco Salvo; Paola Cutroneo; Ilaria Morreale; Achille Patrizio Caputi
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Adverse drug reaction (ADR) notification drop box: an easy way to report ADRs.

Authors:  Dang Amit; Padmanabh V Rataboli
Journal:  Br J Clin Pharmacol       Date:  2008-07-28       Impact factor: 4.335

5.  [Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center)].

Authors:  C Ciorciaro; K Hartmann; M Kuhn
Journal:  Schweiz Med Wochenschr       Date:  1998-02-14

Review 6.  Understanding adverse drug reactions and drug allergies: principles, diagnosis and treatment aspects.

Authors:  Zahra Pourpak; Mohammad R Fazlollahi; Fatemeh Fattahi
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2008-01

Review 7.  Drug-related hospital admissions.

Authors:  T R Einarson
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

8.  Computerized surveillance of adverse drug events in hospital patients.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  JAMA       Date:  1991-11-27       Impact factor: 56.272

9.  Pleasures and pains of running a pharmacovigilance center.

Authors:  R K Dikshit; Chetna Desai; M K Desai
Journal:  Indian J Pharmacol       Date:  2008-02       Impact factor: 1.200

10.  A pharmacovigilance study in the department of medicine of a university teaching hospital.

Authors:  Himanshu Sharma; Mohammed Aqil; Faisal Imam; Mohammad S Alam; Prem Kapur; Krishna K Pillai
Journal:  Pharm Pract (Granada)       Date:  2007-01
View more
  4 in total

1.  First Indian study evaluating role of biochemical investigations and diagnostic tools in detection of adverse drug reactions.

Authors:  Vishal R Tandon; Vijay Khajuria; Kapila Raina; Vivek Mahajan; Aman Sharma; Zahid Gillani
Journal:  J Clin Diagn Res       Date:  2014-09-20

2.  Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis.

Authors:  Israa Alfares; Muhammad Shahid Javaid; Zhibin Chen; Alison Anderson; Ana Antonic-Baker; Patrick Kwan
Journal:  CNS Drugs       Date:  2021-02-12       Impact factor: 5.749

3.  Clinical profiles of adverse drug reactions spontaneously reported at a single Korean hospital dedicated to children with complex chronic conditions.

Authors:  Bomi Kim; Sunwha Zara Kim; Jin Lee; Ae Hee Jung; Sun-Hoi Jung; Hyeon-Joo Hahn; Hye Ryun Kang; Dong In Suh
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

4.  Reporting Rates of Opioid-Related Adverse Events Since 1965 in Canada: A Descriptive Retrospective Study.

Authors:  Maude Lavallée; Carolina Galli da Silveira; Samuel Akinola; Julie Méthot; Marie-Eve Piché; Anick Bérard; Magalie Thibault; Jennifer Midiani Gonella; Fernanda Raphael Escobar Gimenes; Jacinthe Leclerc
Journal:  Drugs Real World Outcomes       Date:  2021-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.